Enanta Pharmaceuticals Reports Financial Results for its Fourth Quarter and Year Ended September 30, 2017

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fourth Quarter and Year Ended September 30, 2017
ENANTA PHARM (NASDAQ: ENTA) Delayed: 14.06 +0.69 (5.16%)
Previous Close $13.37    52 Week High $34.49 
Open $13.22    52 Week Low $20.39 
Day High $14.12    P/E N/A 
Day Low $12.92    EPS $-3.18 
Volume 401,621